Adaptive Biotechnologies Corp
NASDAQ:ADPT 4:00:00 PM EDT
| Market Cap (Intraday) | 1.25B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $8.29 |
| 50-Day MA | $8.88 |
| 200-Day MA | $8.60 |
Adaptive Biotechnologies Corp Stock, NASDAQ:ADPT
1165 Eastlake Avenue East, Suite 200, Seattle, Washington 98109
United States of America
Phone: +1.206.659.0067
Number of Employees: 790
Description
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.